202 related articles for article (PubMed ID: 25136105)
1. Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010.
Drexler JF; Grard G; Lukashev AN; Kozlovskaya LI; Böttcher S; Uslu G; Reimerink J; Gmyl AP; Taty-Taty R; Lekana-Douki SE; Nkoghe D; Eis-Hübinger AM; Diedrich S; Koopmans M; Leroy EM; Drosten C
Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12889-94. PubMed ID: 25136105
[TBL] [Abstract][Full Text] [Related]
2. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.
Shulman LM; Manor Y; Sofer D; Handsher R; Swartz T; Delpeyroux F; Mendelson E
PLoS One; 2006 Dec; 1(1):e69. PubMed ID: 17183700
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013.
Shulman LM; Martin J; Sofer D; Burns CC; Manor Y; Hindiyeh M; Gavrilin E; Wilton T; Moran-Gilad J; Gamzo R; Mendelson E; Grotto I; ;
Clin Infect Dis; 2015 Apr; 60(7):1057-64. PubMed ID: 25550350
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
Blomqvist S; Bruu AL; Stenvik M; Hovi T
J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
[TBL] [Abstract][Full Text] [Related]
5. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
[TBL] [Abstract][Full Text] [Related]
6. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
7. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment.
Alleman MM; Wannemuehler KA; Weldon WC; Kabuayi JP; Ekofo F; Edidi S; Mulumba A; Mbule A; Ntumbannji RN; Coulibaly T; Abiola N; Mpingulu M; Sidibe K; Oberste MS
J Infect Dis; 2014 Nov; 210 Suppl 1():S62-73. PubMed ID: 25316879
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
9. Determination of antigenic properties of vaccine derived poliovirus strains.
Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
[TBL] [Abstract][Full Text] [Related]
10. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
[TBL] [Abstract][Full Text] [Related]
11. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.
Martín J; Samoilovich E; Dunn G; Lackenby A; Feldman E; Heath A; Svirchevskaya E; Cooper G; Yermalovich M; Minor PD
J Virol; 2002 Nov; 76(21):10921-8. PubMed ID: 12368335
[TBL] [Abstract][Full Text] [Related]
12. Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV.
Lukashev AN; Yarmolskaya MS; Shumilina EY; Sychev DA; Kozlovskaya LI
Virus Res; 2016 Feb; 213():162-164. PubMed ID: 26657881
[TBL] [Abstract][Full Text] [Related]
13. Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo.
Voorman A; Hoff NA; Doshi RH; Alfonso V; Mukadi P; Muyembe-Tamfum JJ; Wemakoy EO; Bwaka A; Weldon W; Gerber S; Rimoin AW
Vaccine; 2017 Oct; 35(42):5693-5699. PubMed ID: 28882442
[TBL] [Abstract][Full Text] [Related]
14. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
15. An outbreak of wild poliovirus in the Republic of Congo, 2010-2011.
Patel MK; Konde MK; Didi-Ngossaki BH; Ndinga E; Yogolelo R; Salla M; Shaba K; Everts J; Armstrong GL; Daniels D; Burns C; Wassilak S; Pallansch M; Kretsinger K
Clin Infect Dis; 2012 Nov; 55(10):1291-8. PubMed ID: 22911642
[TBL] [Abstract][Full Text] [Related]
16. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011.
Gumede N; Lentsoane O; Burns CC; Pallansch M; de Gourville E; Yogolelo R; Muyembe-Tamfum JJ; Puren A; Schoub BD; Venter M
Emerg Infect Dis; 2013 Oct; 19(10):1583-9. PubMed ID: 24047933
[TBL] [Abstract][Full Text] [Related]
17. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.
Green MS; Handsher R; Cohen D; Melnick JL; Slepon R; Mendelsohn E; Danon YL
Vaccine; 1993; 11(1):75-81. PubMed ID: 8381249
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis.
Diamanti E; Ibrahimi B; Tafaj F; Mezini E; Dodbiba A; Dobi V; Catone S; Genovese D; Simeoni P; Fiore L
Vaccine; 1998; 16(9-10):940-8. PubMed ID: 9682341
[TBL] [Abstract][Full Text] [Related]
19. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
J Virol; 2018 May; 92(9):. PubMed ID: 29444940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
